Correlation Between Novo Nordisk and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Fate Therapeutics, you can compare the effects of market volatilities on Novo Nordisk and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Fate Therapeutics.
Diversification Opportunities for Novo Nordisk and Fate Therapeutics
0.9 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Novo and Fate is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Novo Nordisk and Fate Therapeutics
Considering the 90-day investment horizon Novo Nordisk AS is expected to under-perform the Fate Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Novo Nordisk AS is 4.02 times less risky than Fate Therapeutics. The stock trades about -0.14 of its potential returns per unit of risk. The Fate Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 249.00 in Fate Therapeutics on August 31, 2024 and sell it today you would earn a total of 68.00 from holding Fate Therapeutics or generate 27.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. Fate Therapeutics
Performance |
| Timeline |
| Novo Nordisk AS |
| Fate Therapeutics |
Novo Nordisk and Fate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and Fate Therapeutics
The main advantage of trading using opposite Novo Nordisk and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
| Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |